Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Liver transplantation is considered the standard of care for patients with hepatocellular carcinoma (HCC) within the Milan criteria. Liver transplantation in patients with unresectable colorectal cancer with liver-only disease has been shown to be associated with a 5-year overall survival rate of 56 per cent, compared with 9 per cent in patients receiving standard palliative chemotherapy. The aim of the present study was to compare disease-free (DFS) and overall (OS) survival after liver transplantation in patients with HCC and those with colorectal metastases.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Br J Surg

Title: The British journal of surgery

Publisher: Wiley

ISSN (Electronic): 1365-2168

ISSN (Print): 0007-1323

Publication date (Electronic): May 2018

Volume: 105

Issue: 6

Affiliations

[1 ] Department of Oncology, Oslo University Hospital, Oslo, Norway.

[2 ] Department of Mathematics and Natural Science, University of Stavanger, Stavanger, Norway.

[3 ] Section for Transplantation Surgery, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.

[4 ] Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Article

DOI: 10.1002/bjs.10769

PubMed ID: 29532908

SO-VID: 6333341f-b628-4f42-971d-3be6d7367174

History

Data availability:

Comments

Comment on this article

scite_

Cited by 14

See all cited by